NASDAQ:BKYI - BIO-key International Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $6.00
Forecasted Upside: 81.82 %
Number of Analysts: 1
Breakdown:
0 Sell Ratings
0 Hold Ratings
1 Buy Ratings
0 Strong Buy Ratings

^$3.30 As of 08/2/2021 01:00 AM ET

▲ +0.1 (3.13%)

1 month | 3 months | 12 months

Get New BIO-key International Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for BKYI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BKYI

^$6.00

▲ +81.82% Upside Potential

This price target is based on 1 analysts offering 12 month price targets for BIO-key International in the last 3 months. The average price target is $6.00, with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 81.82% upside from the last price of $3.30.

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in BIO-key International. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

2/10/2020

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

5/10/2020

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

8/8/2020

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

11/6/2020

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

2/4/2021

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

5/5/2021

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

7/4/2021

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

8/3/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
3/26/2021	Maxim Group	Upgrade	Hold ➝ Buy	$6.00	High
8/11/2020	Maxim Group	Reiterated Rating	Hold		High
10/4/2019	Maxim Group	Downgrade	Buy ➝ Hold		Low
8/30/2019	Maxim Group	Set Price Target	Buy	$2.00	Low
7/29/2019	Maxim Group	Reiterated Rating	Buy	$2.25	Low
4/2/2019	Maxim Group	Reiterated Rating	Buy	$4.00	Low
11/15/2018	Maxim Group	Reiterated Rating	Buy	$4.00	Medium
8/16/2018	Maxim Group	Lower Price Target	Buy ➝ Buy	$5.50 ➝ $5.00	Low
4/24/2018	Maxim Group	Initiated Coverage	Buy ➝ Buy	$5.50	Medium
3/29/2018	Maxim Group	Set Price Target	Buy	$6.00	High
12/21/2017	Maxim Group	Reiterated Rating	Buy	$5.50	Low
7/13/2017	Maxim Group	Initiated Coverage	Buy ➝ Buy	$5.50	N/A

(Data available from 8/3/2016 forward)

BIO-key International, Inc. engages in the provision of identity and access management (IAM) platform. The firm's products include multi-factor authentication, self-service password reset, single sign-on, fingerprint scanners, and civil and large-scale identification. It offers its services to the education, financial, government, healthcare, manufacturing, and retail industries. The company was founded on January 7, 1993 and is headquartered in Wall, NJ.

Today's Range

Now: $3.30

$3.17

$3.30

50 Day Range

MA: $3.71

$3.13

$4.11

52 Week Range

Now: $3.30

$2.75

$7.20

Volume

45,864 shs

Average Volume

311,310 shs

Market Capitalization

$25.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01

Frequently Asked Questions

What sell-side analysts currently cover shares of BIO-key International?

The following Wall Street sell-side analysts have issued reports on BIO-key International in the last twelve months: Maxim Group.
View the latest analyst ratings for BKYI.

What is the current price target for BIO-key International?

1 Wall Street analysts have set twelve-month price targets for BIO-key International in the last year. Their average twelve-month price target is $6.00, suggesting a possible upside of 81.8%. Maxim Group has the highest price target set, predicting BKYI will reach $6.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $6.00 for BIO-key International in the next year.
View the latest price targets for BKYI.

What is the current consensus analyst rating for BIO-key International?

BIO-key International currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BKYI will outperform the market and that investors should add to their positions of BIO-key International.
View the latest ratings for BKYI.

What other companies compete with BIO-key International?

Other companies that are similar to BIO-key International include Intrusion, B.O.S. Better Online Solutions, Ezenia!, Avistar Communications, China Crescent Enterprises and Invent Ventures.

How do I contact BIO-key International's investor relations team?

BIO-key International's physical mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL NJ, 07719. The technology company's listed phone number is (732) 359-1100 and its investor relations email address is [email protected] The official website for BIO-key International is www.bio-key.com.